AstraZeneca Pharma India Limited has completed the exploration phase for search of a buyer who could act as a Contract Manufacturing Organisation and was unable to find a suitable one. The company will now explore a buyer for its manufacturing site and exit in due course.

The company remains committed to advance access to innovative medicines in India, with a clear ambition to be pioneers in science, lead in specialist disease areas, and transform patient outcomes. The company is fully cognizant of the impact this change can bring and its first responsibility will be towards its employees and meeting the needs of its patients by ensuring an uninterrupted supply of medicines.